Clearmind Medicine (NASDAQ: CMND) reported Q4 2023 earnings per share (EPS) of -$0.90, up 96.37% year over year. Total Clearmind Medicine earnings for the quarter were -$1.37 million. In the same quarter last year, Clearmind Medicine's earnings per share (EPS) was -$24.80.
As of Q2 2024, Clearmind Medicine's earnings has grown year over year. Clearmind Medicine's earnings in the past year totalled -$8.09 million.
What was CMND's revenue last quarter?
Clearmind Medicine (NASDAQ: CMND) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Clearmind Medicine's revenue was $0.00.
What was CMND's revenue growth in the past year?
As of Q2 2024, Clearmind Medicine's revenue has grown null year over year. Clearmind Medicine's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.